Response to treatment in a patient with gouty arthritis and tophi evaluated by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography.
From the *Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; and †School of Medicine, Catholic University of the Sacred Heart, Rome; and ‡Department of Nuclear Medicine, University of Brescia and Spedali Civili of Brescia, Brescia, Italy.
Giorgio
G
Treglia
Luca
L
Giovanella
Barbara
B
Muoio
Francesco
F
Bertagna
D000368:Aged; D015210:Arthritis, Gouty / Q000000981:diagnostic imaging* / Q000188:drug therapy; D003078:Colchicine / Q000627:therapeutic use*; D019788:Fluorodeoxyglucose F18; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome
D006074:Gout Suppressants; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003078:Colchicine